Q&A: BeiGene ex­ec re­flects on path that led them to se­lect NJ for a ma­jor man­u­fac­tur­ing/R&D cam­pus

BeiGene has cho­sen New Jer­sey as its next US home, and the plans are mas­sive.

The com­pa­ny will re­cruit hun­dreds of peo­ple to work at its sixth US lo­ca­tion, a 42-acre R&D and man­u­fac­tur­ing cam­pus, in Hopewell, NJ, that is set to go up rough­ly 60 miles away from its oth­er New Jer­sey of­fice.

The fa­cil­i­ty will in­clude com­mer­cial-stage man­u­fac­tur­ing, clin­i­cal R&D and the “BeiGene Cen­ter for Phar­ma­covig­i­lance In­no­va­tion.” The con­struc­tion is ex­pect­ed to be com­plet­ed in mid-2023, and head of tech­ni­cal op­er­a­tions Michael Gar­vey is set to over­see the op­er­a­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER